MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-18-2026
Charles River Laboratories International EV/EBITDA Ratio 2011-2026 | CRL
Annual EV/EBITDA Ratio Charles River Laboratories International
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 22 | 20.1 | 16.9 | 14.7 | 14.7 | 17.2 | 14.4 | 14.4 | 13.1 | 9.97 | 11.5 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 22 | 9.97 | 15.4 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M |  Germany |
 |
ICON Public Limited Company
ICLR
|
38 | $ 98.33 | 0.9 % | $ 8.11 B |  Irlanda |
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M |  USA |
 |
Brainsway Ltd.
BWAY
|
-43.6 | $ 13.71 | -0.22 % | $ 99.4 M |  Israel |
 |
Bioventus
BVS
|
26.4 | $ 8.62 | 0.23 % | $ 574 M | USA |
 |
DexCom
DXCM
|
39.5 | $ 64.24 | -1.56 % | $ 25.1 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
-21.2 | $ 25.56 | 0.95 % | $ 710 M | USA |
 |
CareDx, Inc
CDNA
|
-100 | $ 17.01 | 3.4 % | $ 906 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-20.8 | $ 103.57 | 0.29 % | $ 19.5 B | USA |
 |
Guardant Health
GH
|
-28.8 | $ 85.49 | 1.75 % | $ 10.7 B | USA |
 |
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
2.58 | $ 14.77 | 0.61 % | $ 447 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | USA |
|
Biodesix
BDSX
|
-4.25 | $ 17.88 | -6.63 % | $ 2.32 B | USA |
 |
Anixa Biosciences
ANIX
|
-2.25 | $ 2.83 | -1.05 % | $ 91.8 K | USA |
 |
Danaher Corporation
DHR
|
20.1 | $ 187.32 | 0.57 % | $ 134 B | USA |
 |
IQVIA Holdings
IQV
|
24.1 | $ 164.72 | 1.1 % | $ 28.3 B | USA |
 |
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
70.5 | $ 118.94 | 2.92 % | $ 18.9 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 199.7 | -0.46 % | $ 22.2 B | USA |
 |
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B |  Niderland |
 |
Agilent Technologies
A
|
27.4 | $ 111.51 | -0.06 % | $ 33.9 B | USA |
 |
BioNano Genomics
BNGO
|
-7.71 | $ 1.11 | -0.89 % | $ 1.41 M | USA |
 |
DarioHealth Corp.
DRIO
|
-1.05 | $ 9.0 | -0.99 % | $ 255 M | Israel |
 |
Neogen Corporation
NEOG
|
40.3 | $ 9.09 | -2.78 % | $ 1.97 B | USA |
 |
National Research Corporation
NRC
|
21 | $ 16.52 | 0.12 % | $ 370 M | USA |
 |
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | Israel |
 |
Pacific Biosciences of California
PACB
|
-23.8 | $ 1.33 | 4.72 % | $ 399 M | USA |
 |
Co-Diagnostics
CODX
|
3.62 | - | - | $ 79.8 M | USA |
 |
Medpace Holdings
MEDP
|
30.7 | $ 450.41 | 1.48 % | $ 13 B | USA |
 |
Celcuity
CELC
|
-2.38 | $ 114.22 | 3.11 % | $ 4.51 B | USA |
 |
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Mettler-Toledo International
MTD
|
827 | $ 1 173.74 | 0.49 % | $ 24.2 B |  Schweiz |
 |
Personalis
PSNL
|
-7.07 | $ 6.72 | 1.97 % | $ 398 M | USA |
 |
NeoGenomics
NEO
|
-33.5 | $ 7.88 | -1.25 % | $ 1.01 B | USA |
 |
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
-19.5 | $ 187.85 | -1.29 % | $ 18.5 B | USA |
 |
Sotera Health Company
SHC
|
24.8 | $ 13.42 | 0.71 % | $ 3.81 B | USA |
 |
Invitae Corporation
NVTA
|
-10.7 | - | - | $ 21.2 M | USA |
 |
OPKO Health
OPK
|
25.9 | $ 1.19 | 2.59 % | $ 826 M | USA |